Conformational isomerism and hydrogen-bonded motifs of anion assisted supramolecular self-assemblies using Cu/Co salts and pyridine-4-acetamide

Six novel metal-organic complex assemblies constructed from a conformation-flexible ligand - pyridine-4-acetamide (PAT) and inorganic Cu^II and Co^II salts have been synthesized and structurally characterized by single crystal X-ray diffraction analysis. Crystal structure analysis reveals five types of architectures by variation of metal salts. In {[Cu(PAT)₂Cl₂]}_n (1) and {[Co(PAT)₂Cl₂]}_n (3), PAT ligands bridge metal centers to form one-dimensional chains. The chains are extended to three dimensions with the aid of two types of hydrogen bonded motifs () and (12)). {[Cu(PAT)₂(NO₃)](NO₃)(THF)}_n (5) which exhibits two-dimensional coordinating layers forms open channels filled with solvent molecules. In [Cu(PAT)₂Cl₂] (2), [Co(PAT)₂Cl₂] (4) and [Co(PAT)₄(H₂O)₂](NO₃)₂(THF)₂ (6), PAT is observed as a monofunctional ligand. Complex 2 forms one-dimensional hydrogen bonded chains. Crystal structure of complex 4 has a two-dimensional infinite hydrogen-bonded network with and motifs formed by complementary amide-amide hydrogen bonds. [Co(PAT)₄(H₂O)₂](NO₃)₂(THF)₂ (6) crystallizes in centrosymmetric I4₁/a space group. Complex 6 forms chiral channels which are filled with twisted solvent helices and anion helices. Within each channel the solvent helix and the anion helix have the same handedness; and adjacent channels have opposite handedness. Complexes 1, 2 and complexes 3, 4 illustrate examples of conformational supramolecular isomerism in {[Cu(PAT)₂Cl₂]}_∞ and {[Co(PAT)₂Cl₂]}_∞, respectively. In these complexes, changes of PAT conformations and coordination geometry of metal center induced the structural versatility.     

Precise pathological classification of non-small cell lung adenocarcinoma and squamous carcinoma based on an integrated platform of targeted metabolome and lipidome

Metabolomics - The triglyceride–glucose (TyG) index has been considered as insulin resistance (IR) assessment index. The current study aimed to verify the reliability of the TyG index as an...     

UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance

UBE2O, an E2/E3 hybrid ubiquitin-protein ligase, has been implicated in the regulation of adipogenesis, erythroid differentiation, and tumor proliferation. However, its role in cancer radioresistance remains completely unknown. Here, we uncover that UBE2O interacts and targets Mxi1 for ubiquitination and degradation at the K46 residue. Furthermore, we show that genetical or pharmacological blockade of UBE2O impairs tumor progression and radioresistance in lung cancer in vitro and in vivo, and these effects can be restored by Mxi1 inhibition. Moreover, we demonstrate that UBE2O is overexpressed and negatively correlated with Mxi1 protein levels in lung cancer tissues. Collectively, our work reveals that UBE2O facilitates tumorigenesis and radioresistance by promoting Mxi1 ubiquitination and degradation, suggesting that UBE2O is an attractive radiosensitization target for the treatment of lung cancer.Subject terms: Tumour biomarkers, Preclinical research